| Project name: | The impact of menopause on the vasoregulatory role of the sulfide signaling pathway in cardiovascular complications of type II diabetes |
| Acronym: | sulfidemenopause |
| Project number: | APVV-24-0150 |
| Project duration: | 1.9. 2025-31.8. 2029 |
| Project coordinator: | RNDr. Soňa Čačanyiová, PhD. |
| Project partner: | Institute of Experimental Endocrinology, Biomedical Center of the Slovak Academy of Sciences, v.v.i. |
| Domestic cooperation: | II. Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital in Bratislava |
| Foreign cooperation: | Institute of Clinical and Experimental Medicine (IKEM), Prague, Czech Republic – a laboratory focused on the analysis of glucose and lipid metabolism Attoquant Diagnostics GmbH, Vienna, Austria – using the patented RAS Fingerprint™ method, the laboratory provides detailed biochemical characterization of the renin-angiotensin system |
| Total project budget: | €388,700 |
| Main project objective: | To investigate the role of hydrogen sulfide (H₂S) and its signaling pathway in the regulation of vascular functions with regard to the impact of menopause and type II diabetes. |
